RACHEL DOERR: Open Payments
NPI 1023531506 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,262 in 115 payments from 17 companies in 2025. Trend: 2023 $859 · 2024 $1,805 · 2025 $2,262
Food & beverage: $1,968Education: $294
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $361 |
| Janssen Biotech, Inc. | 12 | $286 |
| GENZYME CORPORATION | 10 | $249 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $206 |
| LEO Pharma Inc. | 9 | $176 |
| Galderma Laboratories, L.P. | 13 | $173 |
| Novartis Pharmaceuticals Corporation | 8 | $169 |
| E.R. Squibb & Sons, L.L.C. | 8 | $162 |
| Regeneron Healthcare Solutions, Inc. | 6 | $155 |
| UCB, Inc. | 8 | $149 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, NEMLUVIO, Sotyktu, Bimzelx, ADBRY, COSENTYX.
Industry payments across FL — which companies pay providers there.
